A COHORT STUDY OF SERUM TESTOSTERONE AND HEPATOCELLULAR-CARCINOMA IN SHANGHAI, CHINA

被引:83
|
作者
YUAN, JM
ROSS, RK
STANCZYK, FZ
GOVINDARAJAN, S
GAO, YT
HENDERSON, BE
YU, MC
机构
[1] SHANGHAI CANC INST,SHANGHAI 200032,PEOPLES R CHINA
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,SCH MED,DEPT OBSTET & GYNECOL,LOS ANGELES,CA 90033
[4] UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033
关键词
D O I
10.1002/ijc.2910630405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A nested case-control study of HCC based on a cohort of 18,244 middle-aged men in Shanghai, China, who had been followed for an average of 5.3 years, was conducted. Our hypothesis dealt with the possible role of testosterone in the etiology of HCC, which shows a minimum of a 2- to 3-fold male excess in all populations world-wide. Seventy-six incident cases of HCC and 410 control subjects drawn from the cohort and individually matched to the cases by age (within 1 year), time of blood sample collection (within month) and neighborhood of residence were assessed for serum HBsAg, anti-HBc, anti-HBs, anti-HCV and testosterone. Among controls, serum testosterone levels were similar between those who had no markers of HBV infection, those who were positive for anti-HBs only and those who were positive for anti-HBc but negative for HBsAg. However, the geometric mean level of testosterone in HBsAg-positive controls was 21% higher relative to HBsAg-negative controls and the difference was statistically significant (2-sided p = 0.0006). Relative to controls, HCC cases had a significantly higher mean level of testosterone at the time of recruitment (570 vs. 485 ng/dl, 2-sided p = 0.0005), but the difference war explicable on the basis of a higher proportion of HBsAg-positive individuals among cases than controls (p = 0.42 after adjustment for HBsAg status). (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:491 / 493
页数:3
相关论文
共 50 条
  • [1] ELEVATED SERUM TESTOSTERONE LEVELS AND RISK OF HEPATOCELLULAR-CARCINOMA
    YU, MW
    CHEN, CJ
    CANCER RESEARCH, 1993, 53 (04) : 790 - 794
  • [2] SERUM LEVELS OF ESTROGENS AND TESTOSTERONE IN CIRRHOTIC MEN WITH AND WITHOUT HEPATOCELLULAR-CARCINOMA
    NAGASUE, N
    OGAWA, Y
    YUKAYA, H
    OHTA, N
    ITO, A
    GASTROENTEROLOGY, 1985, 88 (03) : 768 - 772
  • [3] SERUM FERRITIN IN HEPATOCELLULAR-CARCINOMA
    ZHOU, XD
    STAHLHUT, MW
    HANN, HL
    LONDON, WT
    HEPATO-GASTROENTEROLOGY, 1988, 35 (01) : 1 - 4
  • [4] IMMUNOCYTOCHEMICAL LOCALIZATION OF TESTOSTERONE IN HUMAN HEPATOCELLULAR-CARCINOMA
    WONG, LYM
    CHAN, SH
    OON, CJ
    RAUFF, A
    HISTOCHEMICAL JOURNAL, 1984, 16 (06): : 687 - 692
  • [5] HEPATOCELLULAR-CARCINOMA IN ITALY - A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CIRRHOSIS
    COLOMBO, M
    SANGIOVANNI, A
    TOMMASINI, MA
    DEFAZIO, C
    DEFRANCHIS, R
    DELNINNO, E
    DIOGUARDI, N
    HEPATOLOGY, 1990, 12 (04) : 941 - 941
  • [6] SERUM IMMUNOREACTIVE CALCITONIN CONCENTRATIONS IN HEPATOCELLULAR-CARCINOMA
    DUGARD, J
    KEW, MC
    DAFONSECA, M
    LEVIN, J
    SOUTH AFRICAN MEDICAL JOURNAL, 1982, 62 (09): : 271 - 273
  • [7] SERUM NEOPTERIN LEVELS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    ANTONIELLO, S
    AULETTA, M
    MAGRI, P
    RUSSO, N
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1992, 373 (11): : 1165 - 1168
  • [8] SERUM FERRITIN IN HEPATOCELLULAR-CARCINOMA - A COMPARISON WITH ALPHAFETOPROTEIN
    MELIA, WM
    BULLOCK, S
    JOHNSON, PJ
    WILLIAMS, R
    CANCER, 1983, 51 (11) : 2112 - 2115
  • [9] LOW SERUM ANDROGENS IN PRIMARY HEPATOCELLULAR-CARCINOMA
    IQBAL, MJ
    CORBISHLEY, TP
    WILKINSON, ML
    KEATING, J
    WILLIAMS, R
    GUT, 1984, 25 (10) : 1131 - 1131
  • [10] SERUM ERYTHROPOIETIN CONCENTRATIONS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    KEW, MC
    FISHER, JW
    CANCER, 1986, 58 (11) : 2485 - 2488